Bausch + Lomb announced today that an affiliate acquired Elios Vision, developer of a minimally invasive glaucoma surgery (MIGS) procedure. The Elios procedure uses an excimer laser to treat glaucoma in conjunction with cataract surgery without implants. Bausch + Lomb believes the deal enhances its glaucoma portfolio which already features pharmaceutical and surgical approaches. Compared […]
Vision
Johnson & Johnson has a new head of Vision Care
Johnson & Johnson (NYSE:JNJ) announced that it appointed Shawn Millerick as president of Vision Care, Americas. Millerick’s appointment went into effect on Nov. 11, 2024. He holds responsibility for defining strategy and driving growth for the company’s Vision Care portfolio in North America and LATAM. That includes the world’s leading contact lens family, Acuvue. Johnson […]
Science Corp. reports positive preliminary clinical data for BCI implant
Brain-computer interface (BCI) developer Science Corporation today announced preliminary clinical trial results for its Prima retina implant. Neuralink co-founder Max Hodak founded Science, which unveiled its Science Eye BCI platform in 2022. The Science Eye is a visual prosthesis that targets retinitis pigmentosa (RP) and dry age-related macular degeneration (AMD), two forms of serious blindness. Science featured […]
Corza launches next-gen microsurgery sutures
Corza Medical announced today at the American Academy of Ophthalmology (AAO) conference that it launched new Onatec ophthalmic microsurgical sutures. The company developed the Onatec needles from highly tempered stainless steel to ensure high bending resistance and durability. Its automated manufacturing process allows for precise needle geometries and accurate grinds. The Westwood, Massachusetts-based company said […]
Horizon Surgical raises $30M Series A for AI-enabled microsurgery robotics
Horizon Surgical Systems announced that it closed a $30 million Series A financing to support its novel surgical robotic platform. Malibu, California-based Horizon aims to advance microsurgery with automated, AI-enabled robotic technology. It plans to use proceeds to advance the development of its Polaris technology platform for eye surgery. Funds could help progress to first-in-human […]
Johnson & Johnson rolls out next-gen intraocular lens
Johnson & Johnson announced today that it expanded the rollout of its latest Tecnis Odyssey presbyopia-correcting intraocular lenses (PC-IOLs). The new full visual range IOL offers a continuous, full range of vision, enabling sight from far, near and in between. It minimzes the need for glasses for those with presbyiopia, according to a news relesae. […]
Neuralink wins FDA breakthrough nod for vision-restoring implant
Neuralink announced on social media that it received FDA breakthrough device designation for its vision-restoring Blindsight implant. On the social media platform X (formerly Twitter), the Elon Musk-backed brain-computer interface (BCI) venture wrote: “We have received Breakthrough Device Designation from the FDA for Blindsight. Join us in our quest to bring back sight to those […]
Samsara Vision appoints new chief commercial officer
Samsara Vision this week announced it promoted Jason Herod to chief commercial officer. Herod was previously the ophthalmic implant device company’s vice president of commercial and international markets. He joined the company in August 2021 with over 24 years of experience in ophthalmic medical device, pharmaceutical, and over-the-counter business. “When Jason joined Samsara Vision three […]
Samsara Vision treats first patients with implantable mini telescope for ophthalmology
Samsara Vision announced that it completed the first procedure with its SING IMT miniature telescope technology in China. Dr. Li Xiaorong performed the first case with the SING IMT (smaller-incision new-generation implantable miniature telescope). It took place this month at the First Affiliated Hospital of Hainan Medical University Lecheng Hospital. “The surgery went well as […]
Roche, Genentech to reintroduce drug-eluting eye implant in U.S. following 2022 recall
Roche subsidiary Genentech today reintroduced its Susvimo therapy for delivery via ocular implant in the U.S. following a recall. The FDA approved a post-approval supplement to Susvimo’s Biologics License Application (BLA). Approval reflects component-level updates made to the ocular implant and refill needle. Roche now plans to work to make Susvimo available in the U.S. […]
Alcon acquires Belkin Vision for up to $385M
Alcon this week announced it is acquiring Belkin Vision for up to $385 million. The deal includes an upfront consideration of $81 million, a cash payment of approximately $65 million, and the potential for up to $385 million in payments contingent upon rigorous sales-based milestones. Alcon is acquiring Belkin Vision’s Direct Selective Laser Trabeculoplasty (DSLT) […]
